when will glp 1 drugs get cheaper The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss What Trump's GLP-1 deal means

India's regulatory authorities have taken firm steps to prevent unsupervised use and malpractices in the supply chain

Nissen says its results are likely to steer prescribers and patients toward favoring a dual agonist like tirzepatide

Arden C

The application of nitric oxide for ocular hypertension treatment

In addition, the high cost of GLP-1 therapies remains a barrier, especially in markets with limited insurance coverage or constrained healthcare budgets The annual cost of treatment with drugs such as Wegovy or Zepbound can exceed several thousand dollars, which may limit accessibility for patients without comprehensive health coverage

The vomiting, nausea, and hypoglycemia estimates were of moderate certainty because of the wide confidence intervals